VHL SYNDROME
Clinical trials for VHL SYNDROME explained in plain language.
Never miss a new study
Get alerted when new VHL SYNDROME trials appear
Sign up with your email to follow new studies for VHL SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shrinks kidney tumors in rare genetic disease
Disease control OngoingThis study tests a daily pill called belzutifan for people with VHL disease who have kidney cancer. The goal is to see if the drug can shrink or eliminate tumors without needing surgery. About 50 adults with VHL and at least one measurable kidney tumor are taking part.
Matched conditions: VHL SYNDROME
Phase: PHASE2 • Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated May 26, 2026 10:35 UTC
-
Scientists dive deep into kidney tumor diversity in rare genetic condition
Knowledge-focused OngoingThis study aims to understand how kidney tumors differ from one another in people with von Hippel-Lindau (VHL) syndrome, a rare genetic condition. Researchers will use advanced imaging, multiple tumor biopsies, and lab-grown tumor models to map these differences. The goal is to l…
Matched conditions: VHL SYNDROME
Sponsor: IRCCS San Raffaele • Aim: Knowledge-focused
Last updated May 26, 2026 10:30 UTC